Skip to main content
. 2017 May 4;6:109–119. doi: 10.2147/IPRP.S129544

Table 2.

Intranasal corticosteroids approved for allergic rhinitisa

Drug Brand name (maker) Indications Formulation Dose per spray (µg) Dosing/administration OTC status
Beclomethasone dipropionate Beconase AQ19 (GSK) Rx: seasonal and perennial allergic rhinitis and nonallergic rhinitis Aqueous suspension in metered-dose manual-pump spray; pH 5.0–6.8; contains BC (0.02%) and phenylethyl alcohol (0.25%) 42 Age ≥12 years: 1–2 sprays per nostril BID
Age ≥6–12 years: 1 spray per nostril BID (up to 2 sprays per nostril BID if not responding)
Rx only
QNASL dry nasal aerosol28 (TEVA) Rx: seasonal and perennial allergic rhinitis Pressurized nonaqueous solution in metered-dose aerosol device with HFA propellant; contains ethanol, no BC 80 and 40 Age ≥12 years: 2 – 80 µg sprays per nostril QD
Age ≥4–11 years: 1 – 40 µg spray per nostril QD
Rx only
Budesonide Rhinocort Aqua21 (AstraZeneca); Rhinocort Allergy29 (McNeil Consumer) Rx: seasonal and perennial allergic rhinitis
OTC: temporary relief of hay fever or other upper respiratory allergy symptoms: nasal congestion, runny nose, sneezing, and itchy nose
Aqueous suspension in metered-dose manual-pump spray; pH 4.5; contains no BC or alcohol 32 Age ≥12 years: up to 4 sprays per nostril QD
Age 6–<12 years: up to 2 sprays per nostril QD
OTC
Ciclesonide Omnaris nasal spray30 (Sunovion)
Zetonna nasal aerosol31 (Sunovion)
Rx: nasal symptoms associated with seasonal allergic rhinitis in adults and children aged ≥6 years and perennial allergic rhinitis in adults and adolescents aged ≥12 years
Rx: Seasonal and perennial allergic rhinitis
Hypotonic aqueous suspension in metered-dose, manual pump spray; pH 4.5; contains no BC or alcohol
Pressurized, metered-dose aerosol canister and actuator containing a solution of ciclesonide in HFA propellant and ethanol; no BC
50
37
Age ≥6 years: 2 sprays per nostril QD
Age ≥12 years: 1 spray per nostril QD
Rx only
Rx only
Flunisolide Various Rx: nasal treatment of the symptoms of seasonal or perennial rhinitis Solution in spray bottle; pH 5.3; contains BC; no alcohol 25 Age 6–14 years: 1 spray per nostril TID or 2 sprays per nostril BID
Age >14 years: 2 sprays per nostril BID/TID
Rx only
Fluticasone furoate Veramyst32 (GSK) Flonase Sensimist
Allergy Relief52 (GSK Consumer Healthcare)
Rx: seasonal and perennial allergic rhinitis
OTC: temporary relief of symptoms due to hay fever or other upper respiratory allergies in children aged ≥2 years and adults: nasal congestion; runny nose; sneezing; itchy nose; and itchy, watery eyes for ages ≥12 years
Aqueous suspension in metering, atomizing spray pump; pH 6; contains BC (0.015%); no alcohol 27.5 Age 2–11 years: 1 spray per nostril QD
Age ≥12 years: 2 sprays per nostril QD
OTCb
Fluticasone propionate Flixonase22 (GSK)
Flonase Allergy Relief50 (GSK Consumer Healthcare)
Rx: seasonal and perennial allergic rhinitis, nasal polyps
OTC: temporary relief of hay fever or other upper respiratory allergy symptoms: nasal congestion; runny nose; sneezing; itchy nose; itchy, watery eyes
Aqueous suspension in metering, atomizing spray pump; pH 5–7; contains BC (0.02%) and phenylethyl alcohol (0.25%) 50 Age 4–11 years: 1 spray per nostril QD
Age ≥12 years: 2 sprays per nostril QD
OTC
Mometasone furoate Nasonex20 (Merck Sharp & Dohme) Rx: seasonal and perennial allergic rhinitis, nasal polyps, prophylaxis of seasonal allergic rhinitis
OTC: treatment of allergic rhinitis (scope of indication varies by country)
Aqueous suspension in metered-dose, manual pump spray; pH 4.3–4.9; contains BC; no alcohol 50 Age 2–11 years: 1 spray per nostril QD
Age ≥12 years: 2 sprays per nostril QD
OTC (outside the USA)
Triamcinolone acetonide Nasacort23 (Sanofi)
Nasacort Allergy 24HR33 (Chattem, Inc., a Sanofi Company)
Rx: seasonal and perennial allergic rhinitis
OTC: temporary relief of hay fever or other upper respiratory allergy symptoms: nasal congestion; runny nose; sneezing; itchy nose
Aqueous suspension in metered-dose pump spray; pH 4.5–6.0; contains BC; no alcohol 55 Age 2–5 years: 1 spray per nostril QD
Age 6–11 years: 1 spray per nostril QD
Age ≥12 years: 2 sprays per nostril QD/BID
OTC

Notes:

a

Indications, dosage, and prescription status may vary by country.

b

Approved by US Food and Drug Administration for OTC use as of August 2016; OTC product is anticipated to be available commercially in 2017.

Abbreviations: BC, benzalkonium chloride; BID, twice daily; HFA, hydrofluoroalkane; OTC, over-the-counter; QD, once daily; Rx, prescription; TID, three times daily.